Connection
David Mathes to Skin Neoplasms
This is a "connection" page, showing publications David Mathes has written about Skin Neoplasms.
|
|
Connection Strength |
|
|
|
|
|
0.306 |
|
|
|
-
Wang Z, Ma J, Zhang H, Ramakrishna R, Mintzlaff D, Mathes DW, Pomfret EA, Lucia MS, Gao D, Haverkos BM, Wang Z. CCR4-IL2 bispecific immunotoxin is more effective than brentuximab for targeted therapy of cutaneous T-cell lymphoma in a mouse CTCL model. FEBS Open Bio. 2023 07; 13(7):1309-1319.
Score: 0.135
-
Wang H, Wang Z, Zhang H, Qi Z, Johnson AC, Mathes D, Pomfret EA, Rubin E, Huang CA, Wang Z. Bispecific human IL2-CCR4 immunotoxin targets human cutaneous T-cell lymphoma. Mol Oncol. 2020 05; 14(5):991-1000.
Score: 0.109
-
Sullivan SR, Liu DZ, Mathes DW, Isik FF. Head and neck malignant melanoma: local recurrence rate following wide local excision and immediate reconstruction. Ann Plast Surg. 2012 Jan; 68(1):33-6.
Score: 0.062